Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 6, Issue 4, Pages 575-585Publisher
TAYLOR & FRANCIS AS
DOI: 10.1586/14737159.6.4.575
Keywords
biomarker; critical path research; metabolomics; pharmacology; quantitative disease model; systems biology; toxicology; translational path research
Categories
Funding
- MRC [G0400192] Funding Source: UKRI
- Medical Research Council [G0400192] Funding Source: Medline
Ask authors/readers for more resources
Metabolites are the key regulators of systems homeostasis. As such, concentration changes of specific groups of metabolites may reflect systemic responses to environmental, therapeutic or genetic interventions. Thus, the study of metabolites is a powerful tool for the characterization of complex phenotypes as well as for the development of biomarkers for specific physiological responses. Therefore, metabolomics is a valuable platform for studies of complex diseases and the development of new therapies, both in nonclinical disease model characterization and clinical settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available